(Q35006785)

5 August 2017

title

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck (English)

1 reference

5 August 2017

main subject

head and neck carcinoma

1 reference

T Bauernhofer

1

1 reference

5 August 2017

M Pichler

2

1 reference

5 August 2017

E Wieckowski

3

1 reference

5 August 2017

J Stanson

4

1 reference

5 August 2017

A Aigelsreiter

5

1 reference

5 August 2017

A Griesbacher

6

1 reference

5 August 2017

A Groselj-Strele

7

1 reference

5 August 2017

A Linecker

8

1 reference

5 August 2017

H Samonigg

9

1 reference

5 August 2017

C Langner

10

1 reference

5 August 2017

T L Whiteside

11

1 reference

5 August 2017

language of work or name

English

0 references

publication date

19 April 2011

1 reference

British Journal of Cancer

5 August 2017

published in

1 reference

5 August 2017

volume

104

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1641-1648

1 reference

Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

New mechanisms for PRLr action in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Complex prolactin crosstalk in breast cancer: new therapeutic implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/neu transgenic mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Impaired turnover of prolactin receptor contributes to transformation of human breast cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin and breast cancer etiology: an epidemiologic perspective

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin-induced expression of vascular endothelial growth factor via Egr-1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin as an autocrine/paracrine growth factor in human cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Tissue microarrays for high-throughput molecular profiling of tumor specimens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Prolactin signaling in mammary gland development.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Characterization of a monoclonal antibody against human prolactin receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.131

Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.131

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.131

Role of prolactin/prolactin receptor signaling in human breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101909

Serum Prognostic Markers in Head and Neck Cancer

26 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.131

Cellular expression of growth hormone and prolactin receptors in human breast disorders

21 January 2018

1 reference

12 December 2020

Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture

1 reference

12 December 2020

Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience

1 reference

12 December 2020

A role for growth hormone and prolactin in leukaemia and lymphoma?

1 reference

12 December 2020

Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases

1 reference

12 December 2020

Prolactin—a novel neuroendocrine regulator of human keratin expression in situ

1 reference

12 December 2020

Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma

1 reference

12 December 2020

Circulating markers and growth factors as prognosticators in men with advanced tongue cancer

1 reference

12 December 2020

Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study

1 reference

12 December 2020

Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2011.131

1 reference

5 August 2017

1 reference

5 August 2017

1 reference